ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,921Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 387

$1.19M Total Retail Price of All Prescriptions

Rank: 20 out of 387

709 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 709 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 709 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 13,153 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
OMEPRAZOLE 642 538 1 4
SIMVASTATIN 575 505 2 5
HYDROCODONE-ACETAMINOPHEN 550 416 S3 3 1
LEVOTHYROXINE SODIUM 549 499 4 2
FUROSEMIDE 546 464 5 7
GABAPENTIN 438 335 6 10
PRAVASTATIN SODIUM 416 364 7 15
LISINOPRIL 385 305 8 3
AMLODIPINE BESYLATE 292 265 9 6
CARVEDILOL 287 237 10 21
METFORMIN HCL 264 188 11 8
TRAMADOL HCL 254 196 12 14
METOPROLOL TARTRATE 241 217 13 11
POTASSIUM CHLORIDE 229 184 14 9
ZOLPIDEM TARTRATE 227 127 15 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 212 182 16 30
CITALOPRAM HBR 188 169 17 19
WARFARIN SODIUM 156 145 18 17
HYDROCHLOROTHIAZIDE 155 132 19 12
TAMSULOSIN HCL 151 135 20 32
TRAZODONE HCL 149 108 21 37
MELOXICAM 147 126 22 22
METOPROLOL SUCCINATE 144 128 23 18
ATORVASTATIN CALCIUM 137 110 24 13
NEXIUM 133 81 25 26
NAMENDA 132 132 26 35
ALENDRONATE SODIUM 125 125 27 31
FLUTICASONE PROPIONATE 123 85 28 29
LOSARTAN POTASSIUM 121 117 29 24
CEFDINIR 120 113 30 163
DILTIAZEM ER 118 103 31 139
ALLOPURINOL 118 98 31 28
CYMBALTA 117 94 33 44
POLYETHYLENE GLYCOL 3350 117 109 33 57
DONEPEZIL HCL 108 108 35 27
PROAIR HFA 105 76 36 47
LOSARTAN-HYDROCHLOROTHIAZIDE 102 96 37 65
DIGOXIN 101 101 38 40
ISOSORBIDE MONONITRATE ER 101 92 38 59
SULFAMETHOXAZOLE-TRIMETHOPRIM 98 81 40 90
ROPINIROLE HCL 98 84 40 91
GLIMEPIRIDE 94 61 42 50
SPIRONOLACTONE 91 79 43 67
CLOPIDOGREL 89 86 44 25
CYCLOBENZAPRINE HCL 88 33 R 45 42
CLONIDINE HCL 87 82 46 38
SERTRALINE HCL 82 60 47 23
AMITRIPTYLINE HCL 82 46 R 47 62
SINGULAIR 80 71 49 83
GEMFIBROZIL 78 65 50 93
DETROL LA 73 62 51 178
PLAVIX 73 70 51 39
GLYBURIDE 73 67 R 51 58
METOCLOPRAMIDE HCL 71 42 54 125
AMLODIPINE BESYLATE-BENAZEPRIL 68 68 55 54
AMOX TR-POTASSIUM CLAVULANATE 68 54 55 131
AZITHROMYCIN 67 58 57 49
CARBIDOPA-LEVODOPA 65 44 58 104
DIOVAN 64 64 59 33
KLOR-CON M20 61 57 60 76
PROMETHAZINE HCL 61 37 R 60 82
ESTRADIOL 60 58 R 62 105
CELEBREX 60 52 62 72
PREMARIN 59 52 R 64 77
RANITIDINE HCL 59 53 64 45
PREDNISONE 57 56 66 43
LANTUS 56 46 67 51
OXYBUTYNIN CHLORIDE 54 52 68 134
ADVAIR DISKUS 54 51 68 41
FENTANYL 53 50 S2 70 80
DILTIAZEM 24HR CD 53 49 70 118
DILTIAZEM HCL 52 52 72 187
MORPHINE SULFATE ER 52 32 S2 72 79
MIRTAZAPINE 51 51 74 64
LEVEMIR 50 38 75 169
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 5, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.